The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of sustained and local delivery of intraperitoneal IL-2 using encapsulated cells in patients with platinum-resistant high-grade serous carcinoma.
 
Helen Clark
Employment - Janssen (I)
Leadership - Janssen (I)
Stock and Other Ownership Interests - Janssen (I); MacroGenics (I)
 
Samira Aghlara-Fotovat
Patents, Royalties, Other Intellectual Property - Encapsulated Cells Expressing IL-12 and Uses Thereof Encapsulated Cells Expressing IL-2 and Uses Thereof Methods of Use and Administration of Encapsulated Cells
 
Kelly Rangel
No Relationships to Disclose
 
Travis Sims
Research Funding - Bristol Myers Squibb Foundation; Gilead Sciences; NIH (Inst)
 
Bryan Fellman
No Relationships to Disclose
 
Cara Haymaker
Stock and Other Ownership Interests - Briacell
Consulting or Advisory Role - Regeneron
Research Funding - Avenge Bio (Inst); BTG (Inst); Dragonfly Therapeutics (Inst); Iovance Biotherapeutics (Inst); KSQ Therapeutics (Inst); Obsidian Therapeutics (Inst); Sanofi (Inst); Yingli Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Appl No. 62/977, 672 (Inst)
 
Juan Amador Molina
No Relationships to Disclose
 
Amanda Nash
Patents, Royalties, Other Intellectual Property - Co-inventor on suite of patents
 
Jake Schladenhauffen
Employment - Avenge Bio
Stock and Other Ownership Interests - Avenge Bio
Consulting or Advisory Role - Flagship FL68
 
Lauren Jansen
Employment - Avenge Bio; Flagship Pioneering FL68
Patents, Royalties, Other Intellectual Property - Encapsulated Cells and Methods of Preserving Thereof
 
Ryan Newman
Employment - Avenge Bio; RBL
Stock and Other Ownership Interests - Avenge Bio; RBL
 
Oladapo Yeku
Employment - Massachusetts General Hospital Cancer Center; Massachusetts Medical Society
Stock and Other Ownership Interests - hC Bioscience
Honoraria - Medscape
Consulting or Advisory Role - AADi; Gimv; hC Bioscience; TigaTx
Research Funding - Ascendis Pharma A/S (Inst); Avenge Bio, Inc (Inst); Compugen (Inst); Duality Biologics (Inst); GOG Foundatioj (Inst); Immunocore Limited (Inst); Merck (Inst); ProfoundBio (Inst)
Patents, Royalties, Other Intellectual Property - Dr. Yeku has a patent for MUC16 Directed Antibodies for therapeutic applications pending and a patent for Human Artificial Chromosomes for therapeutic applications pending.
Travel, Accommodations, Expenses - ASCO
 
Andrew Blakely
No Relationships to Disclose
 
Cara Mathews
Research Funding - AADI (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); avenge bio (Inst); Deciphera (Inst); Elucida Oncology (Inst); EMD Serono (Inst); Genmab (Inst); Immunogen (Inst); Laekna Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro/GSK (Inst); Volastra Therapeutics (Inst); Zentalis (Inst)
 
Rima Chakrabarti
Stock and Other Ownership Interests - Sentinel Biotherapeutics
(OPTIONAL) Uncompensated Relationships - Dimension Inx, Inc; Sentinel Biotherapeutics
 
Omid Veiseh
Employment - Duracyte; Sentinel Bio; Steer Bio
Leadership - Duracyte; Sentinel Bio; Steer Bio
Stock and Other Ownership Interests - Duracyte; Sentinel Bio; Steer Bio
Consulting or Advisory Role - Duracyte; Sentinel Bio; Steer Bio
Patents, Royalties, Other Intellectual Property - Duracyte; Sentinel Bio; Steer Bio
Travel, Accommodations, Expenses - Duracyte; Sentinel Bio; Steer Bio
 
Amir Jazaeri
Stock and Other Ownership Interests - Avenge Bio; Greenfire Bio
Honoraria - Premier Research
Consulting or Advisory Role - Gerson Lehrman Group; Guidepoint Global; Iovance Biotherapeutics; Macrogenics; Sentinel Bio; Theolytics
Research Funding - AstraZeneca (Inst); Avenge Bio (Inst); GlaxoSmithKline (Inst); immatics (Inst); Imunon (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Stryker
 
Shannon Westin
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Clovis Oncology; Curio Science; Daiichi Sankyo; Eisai; EQRX; Genentech; Gerson Lehrman Group; Gilead Sciences; GlaxoSmithKline; Immunocore; Immunogen; Incyte; Lilly; Loxo/Lilly; Medscape; Merck; Mereo BioPharma; Mersana; Mersana; NGM Biopharmaceuticals; Nuvectis Pharma; Nuvectis Pharma; OncLive; pharma&; Roche; Seagen; Targeted Oncology; Verastem; Vincerx Pharma; Zentalis; ZielBio
Research Funding - AstraZeneca (Inst); Avenge Bio (Inst); Bayer (Inst); Bio-Path Holdings, Inc (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Jazz Pharmaceuticals (Inst); Loxo/Lilly (Inst); Mereo BioPharma (Inst); Novartis (Inst); Nuvectis Pharma (Inst); Pfizer (Inst); Roche/Genentech (Inst); Zentalis (Inst)